title: Effect of temporary IL-2 receptor MAB therapy on islet allograft in autoimmune diabetes.
authors.affiliation: Central Institute of Diabetes, Karlsburg, FRG.
authors.forename: H J
authors.initials: HJ
authors.lastname: Hahn
authors.forename: B
authors.initials: B
authors.lastname: Kuttler
authors.forename: S
authors.initials: S
authors.lastname: Lucke
authors.forename: A
authors.initials: A
authors.lastname: Dunger
authors.forename: W
authors.initials: W
authors.lastname: Besch
authors.forename: H D
authors.initials: HD
authors.lastname: Volk
authors.forename: T
authors.initials: T
authors.lastname: Diamankstein
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000276:immunology / Q000601:surgery*; D003921:Diabetes Mellitus, Experimental / Q000276:immunology / Q000601:surgery*; D005260:Female; D006084:Graft Rejection; D006943:Hyperglycemia / Q000276:immunology; D007515:Islets of Langerhans / Q000276:immunology; D016381:Islets of Langerhans Transplantation; D008297:Male; D051381:Rats; D011913:Rats, Inbred BB; D011917:Rats, Inbred Lew; D015375:Receptors, Interleukin-2 / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D015375:Receptors, Interleukin-2